Document Overview

Pharmas Seek FDA Guidance on Social Media


Author: Eric Newmark
Document #HI220846
PublishedNovember, 2009
Document TypePerspective
Number of Pages     3

Overview

This IDC Health Insights Perspective discusses the state of social media in the pharmaceutical industry, as manufacturers look to the FDA for guidance.

In This Perspective | Learn More
Subscriptions Covered:

Life Science Business Systems Strategy

Regions Covered:

North America, United States

Categories Covered:

Insights: Health Industry, Pharma

Our records show that you do not have access to this document.